Lapidus Daniel, Goldberg Jack, Hobbs Edward H, Ram Saravanan, Clark Glenn T, Enciso Reyes
J Am Dent Assoc. 2016 Jun;147(6):427-37. doi: 10.1016/j.adaj.2016.01.006. Epub 2016 Mar 4.
The authors' objective was to determine whether scientific evidence supports the use of oral premedication to increase the efficacy of inferior alveolar nerve block (IANB) and to decrease endodontic treatment pain in patients with diagnosed irreversible pulpitis.
The authors included randomized controlled trials that involved enteral premedication and 2% lidocaine IANB for adults with irreversible pulpitis compared with placebo. In particular, the authors reviewed studies comparing nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, acetaminophen, and corticosteroids with placebo. The authors searched the following electronic databases: the Cochrane Library, MEDLINE, and Web of Science.
The authors analyzed 9 randomized controlled clinical trials. Patients who took the NSAIDs under study, including ibuprofen, ketorolac, diclofenac, indomethacin, and lornoxicam, 1 hour before endodontic treatment showed statistically significant improvement in the outcome of having "little or no pain" during endodontic treatment compared with patients who took a placebo 1 hour before endodontic treatment (risk ratio [RR], 1.989; 95% confidence interval [CI], 1.495-2.646; P < .001). Benzodiazepines were not as well represented in the literature, but the 2 included studies did not show a significant improvement in patients' having "little or no pain" during endodontic treatment over placebo (RR, 0.989; 95% CI, 0.677-1.444; P = .954).
There is moderate evidence to support the use of oral NSAIDs-in particular, ibuprofen (600 milligrams)-1 hour before the administration of IANB local anesthetic (1.8-3.6 milliliters of 2% lidocaine) to provide additional analgesia to the patient.
作者的目的是确定科学证据是否支持使用口服预防性用药来提高下牙槽神经阻滞(IANB)的疗效,并减轻诊断为不可逆性牙髓炎患者的牙髓治疗疼痛。
作者纳入了随机对照试验,这些试验涉及对患有不可逆性牙髓炎的成人进行肠内预防性用药和2%利多卡因IANB,并与安慰剂进行比较。特别是,作者回顾了比较非甾体抗炎药(NSAIDs)、苯二氮䓬类药物、对乙酰氨基酚和皮质类固醇与安慰剂的研究。作者检索了以下电子数据库:Cochrane图书馆、MEDLINE和科学网。
作者分析了9项随机对照临床试验。与在牙髓治疗前1小时服用安慰剂的患者相比,在牙髓治疗前1小时服用所研究的NSAIDs(包括布洛芬、酮咯酸、双氯芬酸、吲哚美辛和氯诺昔康)的患者在牙髓治疗期间“几乎没有或没有疼痛”的结局有统计学显著改善(风险比[RR],1.989;95%置信区间[CI],1.495 - 2.646;P <.001)。苯二氮䓬类药物在文献中的代表性不足,但纳入的2项研究未显示在牙髓治疗期间患者“几乎没有或没有疼痛”方面比安慰剂有显著改善(RR,0.989;95% CI,0.677 - 1.444;P =.954)。
有中等证据支持在给予IANB局部麻醉剂(1.8 - 3.6毫升2%利多卡因)前1小时使用口服NSAIDs——特别是布洛芬(600毫克)——为患者提供额外的镇痛效果。